Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Hutton

Showing results (71-80 of 79) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 79 results.
European Journal of Biochemistry|May 15, 1993
Molecular characterization of Limulus polyphemus C-reactive protein. I. Subunit compositionG A Tennent, P J Butler, T Hutton, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|June 1, 1993
Strategies for nonradioactive methods in the localization of phosphorylated amino acids in proteinsH E Meyer, B Eisermann, M Heber, et al.
Diabetes Care|December 11, 2020
Parent and Pediatrician Preferences for Type 1 Diabetes Screening in the U.SJessica L Dunne, Anne Koralova, Jessie Sutphin, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|August 15, 2012
Efficient cluster-based catalysts for asymmetric hydrogenation of α-unsaturated carboxylic acidsViktor Moberg, Robin Duquesne, Simone Contaldi, et al.
Philosophical Transactions. Series A, Mathematical, Physical, and Engineering Sciences|June 3, 2009
The OptIPuter microscopy demonstrator: enabling science through a transatlantic lightpathM Ellisman, T Hutton, A Kirkland, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 15, 1992
Apolipoprotein AI mutation Arg-60 causes autosomal dominant amyloidosisA K Soutar, P N Hawkins, D M Vigushin, et al.
QJM : Monthly Journal of the Association of Physicians|October 1, 1995
A new apolipoprotein Al variant, Trp50Arg, causes hereditary amyloidosisD R Booth, S Y Tan, S E Booth, et al.
Neurology|April 1, 1996
Multicenter, placebo-controlled trial of cabergoline taken once daily in the treatment of Parkinson's diseaseJ T Hutton, W C Koller, J E Ahlskog, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|June 8, 2001
Transdermal dopaminergic D(2) receptor agonist therapy in Parkinson's disease with N-0923 TDS: a double-blind, placebo-controlled studyJ T Hutton, L V Metman, T N Chase, et al.
Pageof 8

Showing results (71-80 of 79) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 79 results.
European Journal of Biochemistry|May 15, 1993
Molecular characterization of Limulus polyphemus C-reactive protein. I. Subunit compositionG A Tennent, P J Butler, T Hutton, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|June 1, 1993
Strategies for nonradioactive methods in the localization of phosphorylated amino acids in proteinsH E Meyer, B Eisermann, M Heber, et al.
Diabetes Care|December 11, 2020
Parent and Pediatrician Preferences for Type 1 Diabetes Screening in the U.SJessica L Dunne, Anne Koralova, Jessie Sutphin, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|August 15, 2012
Efficient cluster-based catalysts for asymmetric hydrogenation of α-unsaturated carboxylic acidsViktor Moberg, Robin Duquesne, Simone Contaldi, et al.
Philosophical Transactions. Series A, Mathematical, Physical, and Engineering Sciences|June 3, 2009
The OptIPuter microscopy demonstrator: enabling science through a transatlantic lightpathM Ellisman, T Hutton, A Kirkland, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 15, 1992
Apolipoprotein AI mutation Arg-60 causes autosomal dominant amyloidosisA K Soutar, P N Hawkins, D M Vigushin, et al.
QJM : Monthly Journal of the Association of Physicians|October 1, 1995
A new apolipoprotein Al variant, Trp50Arg, causes hereditary amyloidosisD R Booth, S Y Tan, S E Booth, et al.
Neurology|April 1, 1996
Multicenter, placebo-controlled trial of cabergoline taken once daily in the treatment of Parkinson's diseaseJ T Hutton, W C Koller, J E Ahlskog, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|June 8, 2001
Transdermal dopaminergic D(2) receptor agonist therapy in Parkinson's disease with N-0923 TDS: a double-blind, placebo-controlled studyJ T Hutton, L V Metman, T N Chase, et al.
Pageof 8